WSPN Completes Global Payment Upgrade: Multi-Currency, Multi-Chain Infrastructure Now Live
TORTOLA, British Virgin Islands, Dec. 4, 2025 /PRNewswire/ — Worldwide Stablecoin Payment Network (WSPN) today announced the completion of its Global Payment... Read more.
Appcast Releases Whitepaper: Top Recruiting Trends for 2026
A trusted source for thousands of talent acquisition leaders, the annual whitepaper examines the top recruiting trends that Appcast anticipates in the new year.... Read more.
It’s Showtime! Ladybug and Cat Noir Join Talking Angela on Stage in My Talking Angela 2
Following the Thanksgiving Day rollout of the Miraculous crossover, My Talking Angela 2 saw an uplift of 1.5 million downloads alongside 500k+ engagements across... Read more.
Paradigm Health Raises $78 Million Series B to Make Clinical Trials Part of Routine Care Across the U.S. and Globally
COLUMBUS, Ohio and NEW YORK, Dec. 4, 2025 /PRNewswire/ — Paradigm Health, the technology company rebuilding the clinical research ecosystem, today announced... Read more.
OECD-Cisco research finds stark geographical and generational divides in AI uptake and digital well-being
News Summary Emerging economies, particularly India, Brazil, Mexico, and South Africa, are leading global adoption of generative AI, with younger adults showing... Read more.
BizClik Releases December FinTech Portfolio Featuring JPMorgan and Prudential
New editions of FinTech Magazine and InsurTech Digital highlight global leaders, technology trends and 2026 forecasts across payments, open banking and digital assets... Read more.
Unisys Opens Registration for Its 17th Annual Unisys Innovation Program
Engineering students are empowered to innovate with technologies such as artificial intelligence (AI), quantum computing, and the internet of things (IoT) BENGALURU,... Read more.
Paradigm Health Acquires Flatiron Health’s Clinical Research Business and Forms Strategic Partnership to Rebuild Clinical Research Ecosystem
Partnership creates the largest oncology research network in the United States, enabling clinical trials to reach rural and community-based practices COLUMBUS, Ohio... Read more.
AvenCell Therapeutics Announces IND Clearance and EMA Approval of Clinical Trial Application (CTA) for the QUADvance Study, a Phase I/II trial evaluating AVC-203, a Novel Allogeneic CD19/CD20 CAR-T Investigational Therapy for the Treatment of Relapsed/Refractory B-cell malignancies
CAMBRIDGE, Mass., Dec. 4, 2025 /PRNewswire/ — AvenCell Therapeutics, Inc., a leading clinical-stage cell therapy company focused on advancing both switchable... Read more.
TalentSplit Connects United States Education, Government, Community and Industry through Innovation is Love™
SAN CLEMENTE, Calif., Dec. 4, 2025 /PRNewswire/ — TalentSplit today announced the launch of Innovation is Love™, a collaboration framework that strengthens... Read more.